Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain… Read more
Insulet Corporation (PODD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.091x
Based on the latest financial reports, Insulet Corporation (PODD) has a cash flow conversion efficiency ratio of 0.091x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($125.70 Million) by net assets ($1.38 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Insulet Corporation - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Insulet Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Insulet Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Insulet Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Huazhu Group Ltd
NASDAQ:HTHT
|
0.141x |
|
Huntington Ingalls Industries Inc
NYSE:HII
|
0.128x |
|
Crédit Agricole S.A
PINK:CRARF
|
0.263x |
|
MERCK Kommanditgesellschaft auf Aktien
PINK:MKGAF
|
0.052x |
|
W. R. Berkley Corp
NYSE:WRB
|
0.116x |
|
COSTAR GROUP INC. DL-01
F:RLG
|
N/A |
|
Samsung SDI
KO:006400
|
-0.010x |
|
Tourmaline Oil Corp.
PINK:TRMLF
|
0.052x |
Annual Cash Flow Conversion Efficiency for Insulet Corporation (2004–2024)
The table below shows the annual cash flow conversion efficiency of Insulet Corporation from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.21 Billion | $430.30 Million | 0.355x | +78.60% |
| 2023-12-31 | $732.70 Million | $145.70 Million | 0.199x | -20.39% |
| 2022-12-31 | $476.40 Million | $119.00 Million | 0.250x | +304.05% |
| 2021-12-31 | $556.30 Million | $-68.10 Million | -0.122x | -187.96% |
| 2020-12-31 | $603.60 Million | $84.00 Million | 0.139x | -89.27% |
| 2019-12-31 | $75.90 Million | $98.40 Million | 1.296x | +665.94% |
| 2018-12-31 | $212.10 Million | $35.90 Million | 0.169x | -35.04% |
| 2017-12-31 | $158.52 Million | $41.30 Million | 0.261x | +3.41% |
| 2016-12-31 | $63.15 Million | $15.91 Million | 0.252x | +168.35% |
| 2015-12-31 | $34.05 Million | $-12.55 Million | -0.369x | -446.43% |
| 2014-12-31 | $83.83 Million | $8.92 Million | 0.106x | +296.00% |
| 2013-12-31 | $124.60 Million | $3.35 Million | 0.027x | +104.08% |
| 2012-12-31 | $44.18 Million | $-29.06 Million | -0.658x | -84.52% |
| 2011-12-31 | $71.40 Million | $-25.45 Million | -0.356x | +33.72% |
| 2010-12-31 | $66.23 Million | $-35.62 Million | -0.538x | +42.36% |
| 2009-12-31 | $52.86 Million | $-49.32 Million | -0.933x | +95.17% |
| 2008-12-31 | $4.27 Million | $-82.61 Million | -19.329x | -3440.77% |
| 2007-12-31 | $92.28 Million | $-50.37 Million | -0.546x | -274.58% |
| 2006-12-31 | $-101.77 Million | $-31.82 Million | 0.313x | +1.69% |
| 2005-12-31 | $-66.09 Million | $-20.32 Million | 0.307x | +4.82% |
| 2004-12-31 | $-44.51 Million | $-13.06 Million | 0.293x | -- |